Optiver Holding B.V. Innate Pharma Sa Transaction History

Optiver Holding B.V.

$5.14 Billion
Q2 2024

A detailed history of Optiver Holding B.V. transactions in Innate Pharma Sa stock. As of the latest transaction made, Optiver Holding B.V. holds 87,352 shares of IPHA stock, worth $200,036. This represents 0.0% of its overall portfolio holdings.

Number of Shares

87,352

Previous 70,564 23.79%

Holding current value

$200,036

Previous $203,000 16.75%

% of portfolio

0.0%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$1.94 - $3.0 $32,568 - $50,364	16,788 Added 23.79%	87,352 $169,000
Q1 2024 May 09, 2024	BUY	$2.37 - $2.93 $113,425 - $140,226	47,859 Added 210.79%	70,564 $203,000
Q4 2023 Feb 13, 2024	SELL	$2.17 - $2.93 $363,505 - $490,816	-167,514 Reduced 88.06%	22,705 $63,000
Q3 2023 Nov 13, 2023	BUY	$2.49 - $3.29 $269,973 - $356,711	108,423 Added 132.55%	190,219 $481,000
Q2 2023 Aug 10, 2023	SELL	$2.78 - $3.5 $395,596 - $498,053	-142,301 Reduced 63.5%	81,796 $251,000
Q1 2023 May 11, 2023	BUY	$2.67 - $3.86 $316,563 - $457,653	118,563 Added 112.35%	224,097 $638,000
Q4 2022 Feb 10, 2023	SELL	$1.9 - $3.73 $151,574 - $297,564	-79,776 Reduced 43.05%	105,534 $393,000
Q3 2022 Nov 14, 2022	BUY	$2.0 - $3.2 $6,732 - $10,771	3,366 Added 1.85%	185,310 $371,000
Q2 2022 Aug 10, 2022	BUY	$2.0 - $3.55 $285,940 - $507,543	142,970 Added 366.83%	181,944 $491,000
Q1 2022 May 16, 2022	SELL	$2.7 - $4.8 $400,361 - $711,753	-148,282 Reduced 79.19%	38,974 $131,000
Q4 2021 Feb 14, 2022	BUY	$4.34 - $6.06 $339,461 - $473,995	78,217 Added 71.73%	187,256 $853,000
Q3 2021 Nov 15, 2021	BUY	$3.04 - $8.1 $317,819 - $846,822	104,546 Added 2326.86%	109,039 $673,000
Q2 2021 Aug 16, 2021	SELL	$3.29 - $4.61 $84,852 - $118,896	-25,791 Reduced 85.16%	4,493 $15,000
Q1 2021 May 20, 2021	SELL	$4.09 - $4.83 $103,493 - $122,218	-25,304 Reduced 45.52%	30,284 $131,000
Q1 2021 May 14, 2021	BUY	$4.09 - $4.83 $227,354 - $268,490	55,588 New	55,588 $240,000

Others Institutions Holding IPHA

# of Institutions

Shares Held

242K

Call Options Held

Put Options Held

View Full List

About Innate Pharma SA

Ticker IPHA
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,893,000
Market Cap $183M
Description
Innate Pharma S.A., a biotechnology company, discovers, develops, and commercializes therapeutic antibodies for the treatment of oncology indications in France and internationally. The company's products include Lacutamab (IPH4102), an anti-KIR3DL2 antibody, which is in Phase II clinical trials for the treatment of cutaneous T-cell and periphera...

More about IPHA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Optiver Holding B.V., based on Form 13F filings with the SEC.

News

Stay updated on Optiver Holding B.V. with notifications on news.

Account

Optiver Holding B.V. Innate Pharma Sa Transaction History